How effective is bone-strengthening therapy for multiple myeloma?

Multiple myeloma can activate cells that break down bone, leading to holes, pain, and weakened areas. Bone-strengthening medicines slow this breakdown and may help preserve movement and independence. They can also help manage bone pain, but they do not control the myeloma cells directly.

The expected benefit is shaped by existing bone damage, kidney function, calcium levels, dental health, mobility, and response to myeloma treatment. Imaging and blood tests help the team decide whether the plan is working and whether adjustments are needed.

Tell your haematology team about kidney disease, dental infections, jaw discomfort, planned extractions, and all medicines or supplements. Maintain gentle oral care and attend dental reviews. Keep scheduled blood tests, because kidney function and calcium can affect the choice and timing of therapy.

Ask which activities are safe when bones are fragile. Avoid sudden heavy loading until your team has assessed painful or weakened areas, and use the recommended pain plan rather than waiting for pain to become severe.

Seek urgent assessment for sudden severe back or neck pain, a new inability to walk, limb weakness, numbness, or changes in bladder or bowel control. Contact the team quickly after a fall or minor injury, or for persistent jaw pain, swelling, or exposed bone.

Ask which bone medicine fits your kidney function, how often monitoring is needed, whether a dental check is required, how exercise should be adapted, and how bone treatment will be coordinated with your myeloma regimen.